Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Martos‐Moreno G[au]:

Search results

Items: 1 to 50 of 65

1.

A novel approach to childhood obesity: circulating chemokines and growth factors as biomarkers of insulin resistance.

Rivera P, Martos-Moreno GÁ, Barrios V, Suárez J, Pavón FJ, Chowen JA, Rodríguez de Fonseca F, Argente J.

Pediatr Obes. 2018 Oct 22. doi: 10.1111/ijpo.12473. [Epub ahead of print]

PMID:
30350467
2.

Wind of change in pseudohypoparathyroidism and related disorders: New classification and first international management consensus.

Lecumberri B, Martos-Moreno GÁ, de Nanclares GP.

Endocrinol Diabetes Nutr. 2018 Oct;65(8):425-427. doi: 10.1016/j.endinu.2018.08.002. English, Spanish. No abstract available.

PMID:
30243379
3.

Metabolomics changes in patients with PAPP-A2 deficiency in response to rhIGF1 treatment.

Mastrangelo A, Martos-Moreno GÁ, Rupérez FJ, Chowen JA, Barbas C, Argente J.

Growth Horm IGF Res. 2018 Aug 12;42-43:28-31. doi: 10.1016/j.ghir.2018.08.002. [Epub ahead of print]

PMID:
30119035
4.

[Parental obesity is associated with the severity of childhood obesity and its comorbidities].

Martínez-Villanueva J, González-Leal R, Argente J, Martos-Moreno GÁ.

An Pediatr (Barc). 2018 Jul 24. pii: S1695-4033(18)30301-1. doi: 10.1016/j.anpedi.2018.06.013. [Epub ahead of print] Spanish.

5.

[Influence of neonatal anthropometry on the comorbidities of the obese patient].

González-Leal R, Martínez-Villanueva J, Argente J, Martos-Moreno GÁ.

An Pediatr (Barc). 2018 Jul 2. pii: S1695-4033(18)30227-3. doi: 10.1016/j.anpedi.2018.05.017. [Epub ahead of print] Spanish.

6.

Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement.

Mantovani G, Bastepe M, Monk D, de Sanctis L, Thiele S, Usardi A, Ahmed SF, Bufo R, Choplin T, De Filippo G, Devernois G, Eggermann T, Elli FM, Freson K, García Ramirez A, Germain-Lee EL, Groussin L, Hamdy N, Hanna P, Hiort O, Jüppner H, Kamenický P, Knight N, Kottler ML, Le Norcy E, Lecumberri B, Levine MA, Mäkitie O, Martin R, Martos-Moreno GÁ, Minagawa M, Murray P, Pereda A, Pignolo R, Rejnmark L, Rodado R, Rothenbuhler A, Saraff V, Shoemaker AH, Shore EM, Silve C, Turan S, Woods P, Zillikens MC, Perez de Nanclares G, Linglart A.

Nat Rev Endocrinol. 2018 Aug;14(8):476-500. doi: 10.1038/s41574-018-0042-0. Review.

PMID:
29959430
7.

Clinical management of childhood hyperthyroidism with and without Down syndrome: a longitudinal study at a single center.

Dos Santos TJ, Martos-Moreno GÁ, Muñoz-Calvo MT, Pozo J, Rodríguez-Artalejo F, Argente J.

J Pediatr Endocrinol Metab. 2018 Jul 26;31(7):743-750. doi: 10.1515/jpem-2018-0132.

PMID:
29953411
8.

Frequent and Rare HABP2 Variants Are Not Associated with Increased Susceptibility to Familial Nonmedullary Thyroid Carcinoma in the Spanish Population.

de Randamie R, Martos-Moreno GÁ, Lumbreras C, Chueca M, Donnay S, Luque M, Regojo RM, Mendiola M, Hardisson D, Argente J, Moreno JC.

Horm Res Paediatr. 2018;89(6):397-407. doi: 10.1159/000487395. Epub 2018 Jun 12.

PMID:
29895015
9.

Response to growth hormone in patients with RNPC3 mutations.

Martos-Moreno GÁ, Travieso-Suárez L, Pozo-Román J, Muñoz-Calvo MT, Chowen JA, Frilander MJ, Pérez-Jurado LA, Hawkins FG, Argente J.

EMBO Mol Med. 2018 Jul;10(7). pii: e9143. doi: 10.15252/emmm.201809143. No abstract available.

10.

Heterozygous aggrecan variants are associated with short stature and brachydactyly: Description of 16 probands and a review of the literature.

Sentchordi-Montané L, Aza-Carmona M, Benito-Sanz S, Barreda-Bonis AC, Sánchez-Garre C, Prieto-Matos P, Ruiz-Ocaña P, Lechuga-Sancho A, Carcavilla-Urquí A, Mulero-Collantes I, Martos-Moreno GA, Del Pozo A, Vallespín E, Offiah A, Parrón-Pajares M, Dinis I, Sousa SB, Ros-Pérez P, González-Casado I, Heath KE.

Clin Endocrinol (Oxf). 2018 Jun;88(6):820-829. doi: 10.1111/cen.13581. Epub 2018 Mar 24.

PMID:
29464738
11.

rhIGF-1 Treatment Increases Bone Mineral Density and Trabecular Bone Structure in Children with PAPP-A2 Deficiency.

Hawkins-Carranza FG, Muñoz-Calvo MT, Martos-Moreno GÁ, Allo-Miguel G, Del Río L, Pozo J, Chowen JA, Pérez-Jurado LA, Argente J.

Horm Res Paediatr. 2018;89(3):200-204. doi: 10.1159/000486336. Epub 2018 Feb 16.

PMID:
29455208
12.

[Hypophosphatasia: Clinical manifestations, diagnostic recommendations and therapeutic options].

Martos-Moreno GA, Calzada J, Couce ML, Argente J.

An Pediatr (Barc). 2018 Jun;88(6):356.e1-356.e11. doi: 10.1016/j.anpedi.2017.06.004. Epub 2017 Jul 16. Spanish.

13.

The impact of intrauterine and extrauterine weight gain in premature infants on later body composition.

Saenz de Pipaon M, Dorronsoro I, Álvarez-Cuervo L, Butte NF, Madero R, Barrios V, Coya J, Martínez-Biarge M, Martos-Moreno GÁ, Fewtrell MS, Argente J, Quero J.

Pediatr Res. 2017 Oct;82(4):658-664. doi: 10.1038/pr.2017.123. Epub 2017 Jul 5.

PMID:
28678222
14.

Metabolomics allows the discrimination of the pathophysiological relevance of hyperinsulinism in obese prepubertal children.

Martos-Moreno GÁ, Mastrangelo A, Barrios V, García A, Chowen JA, Rupérez FJ, Barbas C, Argente J.

Int J Obes (Lond). 2017 Oct;41(10):1473-1480. doi: 10.1038/ijo.2017.137. Epub 2017 Jun 7.

PMID:
28588306
15.

Novel genes involved in severe early-onset obesity revealed by rare copy number and sequence variants.

Serra-Juhé C, Martos-Moreno GÁ, Bou de Pieri F, Flores R, González JR, Rodríguez-Santiago B, Argente J, Pérez-Jurado LA.

PLoS Genet. 2017 May 10;13(5):e1006657. doi: 10.1371/journal.pgen.1006657. eCollection 2017 May.

16.

Molecular and clinical analysis of ALPL in a cohort of patients with suspicion of Hypophosphatasia.

Tenorio J, Álvarez I, Riancho-Zarrabeitia L, Martos-Moreno GÁ, Mandrile G, de la Flor Crespo M, Sukchev M, Sherif M, Kramer I, Darnaude-Ortiz MT, Arias P, Gordo G, Dapía I, Martinez-Villanueva J, Gómez R, Iturzaeta JM, Otaify G, García-Unzueta M, Rubinacci A, Riancho JA, Aglan M, Temtamy S, Hamid MA, Argente J, Ruiz-Pérez VL, Heath KE, Lapunzina P.

Am J Med Genet A. 2017 Mar;173(3):601-610. doi: 10.1002/ajmg.a.37991. Epub 2017 Jan 27.

PMID:
28127875
17.

Treatment With Recombinant Human Insulin-Like Growth Factor-1 Improves Growth in Patients With PAPP-A2 Deficiency.

Muñoz-Calvo MT, Barrios V, Pozo J, Chowen JA, Martos-Moreno GÁ, Hawkins F, Dauber A, Domené HM, Yakar S, Rosenfeld RG, Pérez-Jurado LA, Oxvig C, Frystyk J, Argente J.

J Clin Endocrinol Metab. 2016 Nov;101(11):3879-3883. Epub 2016 Sep 20.

18.

[X-linked hypophosphatemic rickets due to mutations in PHEX: Clinical and evolutionary variability].

Martos Moreno GÁ, Aparicio C, de Lucas C, Gil Peña H, Argente J.

An Pediatr (Barc). 2016 Jul;85(1):41-3. doi: 10.1016/j.anpedi.2016.04.012. Epub 2016 May 21. Spanish. No abstract available.

19.

Insulin resistance in prepubertal obese children correlates with sex-dependent early onset metabolomic alterations.

Mastrangelo A, Martos-Moreno GÁ, García A, Barrios V, Rupérez FJ, Chowen JA, Barbas C, Argente J.

Int J Obes (Lond). 2016 Oct;40(10):1494-1502. doi: 10.1038/ijo.2016.92. Epub 2016 May 10.

20.

[Skeletal dysplasias: New medical treatments].

Argente J, Martos Moreno GÁ.

An Pediatr (Barc). 2016 Jul;85(1):1-3. doi: 10.1016/j.anpedi.2016.03.015. Epub 2016 Apr 23. Spanish. No abstract available.

21.

Mutations in pregnancy-associated plasma protein A2 cause short stature due to low IGF-I availability.

Dauber A, Muñoz-Calvo MT, Barrios V, Domené HM, Kloverpris S, Serra-Juhé C, Desikan V, Pozo J, Muzumdar R, Martos-Moreno GÁ, Hawkins F, Jasper HG, Conover CA, Frystyk J, Yakar S, Hwa V, Chowen JA, Oxvig C, Rosenfeld RG, Pérez-Jurado LA, Argente J.

EMBO Mol Med. 2016 Apr 1;8(4):363-74. doi: 10.15252/emmm.201506106.

22.

Vulvar fetal rhabdomyoma mimicking 46XX sex differentiation disorder.

Martos-Moreno GÁ, de Prada I, Riñón C, Argente J.

J Pediatr Endocrinol Metab. 2016 Feb;29(2):217-20. doi: 10.1515/jpem-2015-0202.

PMID:
26352088
23.

Large exonic deletions in POLR3B gene cause POLR3-related leukodystrophy.

Gutierrez M, Thiffault I, Guerrero K, Martos-Moreno GÁ, Tran LT, Benko W, van der Knaap MS, van Spaendonk RM, Wolf NI, Bernard G.

Orphanet J Rare Dis. 2015 Jun 5;10:69. doi: 10.1186/s13023-015-0279-9.

24.

A proteomic approach to obesity and type 2 diabetes.

López-Villar E, Martos-Moreno GÁ, Chowen JA, Okada S, Kopchick JJ, Argente J.

J Cell Mol Med. 2015 Jul;19(7):1455-70. doi: 10.1111/jcmm.12600. Epub 2015 May 9. Review.

25.

[Clinical and radiological findings in a case of pseudohypoparathyroidism type 1a. Albright hereditary osteodystrophy].

Sanz-Fernández M, Muñoz-Calvo MT, Pozo-Román J, Martos-Moreno GA, Argente J.

An Pediatr (Barc). 2015 Jun;82(6):439-41. doi: 10.1016/j.anpedi.2015.01.005. Epub 2015 Feb 24. Spanish. No abstract available.

26.

[Phenotypic and genetic features in neurofibromatosis type 1 in children].

Duat Rodríguez A, Martos Moreno GÁ, Martín Santo-Domingo Y, Hernández Martín A, Espejo-Saavedra Roca JM, Ruiz-Falcó Rojas ML, Argente J.

An Pediatr (Barc). 2015 Sep;83(3):173-82. doi: 10.1016/j.anpedi.2014.10.010. Epub 2014 Dec 23. Spanish.

27.

[Obesity associated metabolic impairment is evident at early ages: Spanish collaborative study].

Martos-Moreno GÁ, Gil-Campos M, Bueno G, Bahillo P, Bernal S, Feliu A, Lechuga-Sancho AM, Palomo E, Ruiz R, Vela A; Grupo de Trabajo de Obesidad de la Sociedad Española de Endocrinología Pediátrica (SEEP).

Nutr Hosp. 2014 Oct 1;30(4):787-93. doi: 10.3305/nh.2014.30.4.7661. Spanish.

28.

Underdiagnosed Beckwith-Wiedemann syndrome among early onset obese children.

Martos-Moreno GÁ, Serra-Juhé C, Pérez-Jurado LA, Argente J.

Arch Dis Child. 2014 Oct;99(10):965-7. doi: 10.1136/archdischild-2014-307097. Epub 2014 Aug 1. No abstract available.

PMID:
25085994
29.

Proteomic analysis allows for early detection of potential markers of metabolic impairment in very young obese children.

Martos-Moreno GÁ, Sackmann-Sala L, Barrios V, Berrymann DE, Okada S, Argente J, Kopchick JJ.

Int J Pediatr Endocrinol. 2014;2014(1):9. doi: 10.1186/1687-9856-2014-9. Epub 2014 Jun 10.

30.

Principles and pitfalls in the differential diagnosis and management of childhood obesities.

Martos-Moreno GÁ, Barrios V, Muñoz-Calvo MT, Pozo J, Chowen JA, Argente J.

Adv Nutr. 2014 May 14;5(3):299S-305S. doi: 10.3945/an.113.004853. Print 2014 May. Review.

31.

The "glacier crevice" sign, from image to diagnosis.

Martos-Moreno GÁ, Argente J.

J Pediatr. 2014 May;164(5):1237-1237.e1. doi: 10.1016/j.jpeds.2014.01.026. Epub 2014 Feb 22. No abstract available.

PMID:
24565426
32.

Defective minor spliceosome mRNA processing results in isolated familial growth hormone deficiency.

Argente J, Flores R, Gutiérrez-Arumí A, Verma B, Martos-Moreno GÁ, Cuscó I, Oghabian A, Chowen JA, Frilander MJ, Pérez-Jurado LA.

EMBO Mol Med. 2014 Mar;6(3):299-306. doi: 10.1002/emmm.201303573. Epub 2014 Jan 30.

33.

[Bardet-Biedl syndrome: diagnostic usefulness of exome sequencing].

Martos Moreno GÁ, Rodríguez-Santiago B, González Gutiérrez-Solana L, Pérez-Jurado LA, Argente J.

An Pediatr (Barc). 2014 Mar;80(3):e100-1. doi: 10.1016/j.anpedi.2013.09.005. Epub 2013 Oct 26. Spanish. No abstract available.

34.

[Endocrinological outcome in children and adolescents survivors of central nervous system tumours after a 5 year follow-up].

Güemes Hidalgo M, Muñoz Calvo MT, Fuente Blanco L, Villalba Castaño C, Martos Moreno GA, Argente J.

An Pediatr (Barc). 2014 Jun;80(6):357-64. doi: 10.1016/j.anpedi.2013.06.039. Epub 2013 Oct 6. Spanish.

35.

[Natural history of isolated increased thyrotropin (TSH) levels in childhood].

Pérez Pérez A, Martínez-Villanueva Fernández J, Martos-Moreno GÁ, Argente J.

An Pediatr (Barc). 2014 Mar;80(3):e90-1. doi: 10.1016/j.anpedi.2013.07.004. Epub 2013 Sep 26. Spanish. No abstract available.

36.

[Adrenal tumours in childhood].

Martos-Moreno GA, Pozo-Román J, Argente J.

An Pediatr (Barc). 2013 Sep;79(3):187.e1-187.e16. doi: 10.1016/j.anpedi.2013.04.032. Epub 2013 Jun 21. Spanish.

37.

[Blood cell chimerism in dizygotic twins conceived by in vitro fertilization].

Martos-Moreno GÁ, Campos C, Flores R, Yturriaga R, Pérez-Jurado LA, Argente J.

An Pediatr (Barc). 2013 Oct;79(4):248-52. doi: 10.1016/j.anpedi.2013.04.005. Epub 2013 May 30. Spanish.

38.

Adipokines in childhood obesity.

Martos-Moreno GÁ, Barrios V, Chowen JA, Argente J.

Vitam Horm. 2013;91:107-42. doi: 10.1016/B978-0-12-407766-9.00006-7.

PMID:
23374715
39.

A novel melanocortin-4 receptor mutation MC4R-P272L associated with severe obesity has increased propensity to be ubiquitinated in the ER in the face of correct folding.

Granell S, Serra-Juhé C, Martos-Moreno GÁ, Díaz F, Pérez-Jurado LA, Baldini G, Argente J.

PLoS One. 2012;7(12):e50894. doi: 10.1371/journal.pone.0050894. Epub 2012 Dec 12.

40.

[Adipokines in healthy and obese children].

Martos-Moreno GA, Kopchick JJ, Argente J.

An Pediatr (Barc). 2013 Mar;78(3):189.e1-189.e15. doi: 10.1016/j.anpedi.2012.10.008. Epub 2012 Nov 24. Review. Spanish.

41.

[Anatomical heterogeneity in the proteome of human subcutaneous adipose tissue].

Martos-Moreno GA, Sackmann-Sala L, Berryman DE, Blome DW, Argente J, Kopchick JJ.

An Pediatr (Barc). 2013 Mar;78(3):140-8. doi: 10.1016/j.anpedi.2012.10.010. Epub 2012 Nov 24. Spanish.

42.

[Graves' ophthalmopathy].

Caballero Mora FJ, Martos Moreno GA, Gutiérrez Partida B, Argente J.

An Pediatr (Barc). 2012 Nov;77(5):355-6. doi: 10.1016/j.anpedi.2012.04.007. Epub 2012 Jun 6. Spanish. No abstract available.

43.

[Infantile hypophosphatasia].

Caballero Mora FJ, Martos Moreno GÁ, García Esparza E, Argente J.

An Pediatr (Barc). 2012 Jun;76(6):368-9. doi: 10.1016/j.anpedi.2012.01.019. Epub 2012 Mar 2. Spanish. No abstract available.

44.

[Lactobezoar in clinical onset of diabetes mellitus type 1 with coeliac disease].

Caballero Mora FJ, Martos Moreno GA, Martínez Gómez MJ, Argente J.

An Pediatr (Barc). 2012 Jun;76(6):366-7. doi: 10.1016/j.anpedi.2012.01.009. Epub 2012 Feb 22. Spanish. No abstract available.

45.

Circulating kisspeptin levels exhibit sexual dimorphism in adults, are increased in obese prepubertal girls and do not suffer modifications in girls with idiopathic central precocious puberty.

Pita J, Barrios V, Gavela-Pérez T, Martos-Moreno GÁ, Muñoz-Calvo MT, Pozo J, Rovira A, Argente J, Soriano-Guillén L.

Peptides. 2011 Sep;32(9):1781-6. doi: 10.1016/j.peptides.2011.07.016. Epub 2011 Jul 30.

PMID:
21827808
46.

[Paediatric obesities: from childhood to adolescence].

Martos-Moreno GA, Argente J.

An Pediatr (Barc). 2011 Jul;75(1):63.e1-23. doi: 10.1016/j.anpedi.2011.03.018. Epub 2011 May 23. Review. Spanish.

47.

[Analysis of insulin and cytokines during development using a multiplexed immunoassay: implications in pediatrics].

Martos-Moreno GA, Burgos-Ramos E, Canelles S, Argente J, Barrios V.

An Pediatr (Barc). 2011 Jun;74(6):356-62. doi: 10.1016/j.anpedi.2010.11.025. Epub 2011 Feb 24. Spanish.

48.

Serum visfatin and vaspin levels in prepubertal children: effect of obesity and weight loss after behavior modifications on their secretion and relationship with glucose metabolism.

Martos-Moreno GÁ, Kratzsch J, Körner A, Barrios V, Hawkins F, Kiess W, Argente J.

Int J Obes (Lond). 2011 Oct;35(10):1355-62. doi: 10.1038/ijo.2010.280. Epub 2011 Jan 25.

PMID:
21266955
49.

[Therapeutic approach in a giant cystic prolactinoma].

Arguinzoniz L, Muñoz-Calvo MT, Pozo J, Martos-Moreno GÁ, Argente J.

An Pediatr (Barc). 2010 Nov;73(5):290-1. doi: 10.1016/j.anpedi.2010.07.014. Spanish. No abstract available.

50.

Effect of recombinant growth hormone on leptin, adiponectin, resistin, interleukin-6, tumor necrosis factor-α and ghrelin levels in growth hormone-deficient children.

López-Siguero JP, López-Canti LF, Espino R, Caro E, Fernández-García JM, Gutiérrez-Macías A, Rial JM, Lechuga JL, Macías F, Martínez-Aedo MJ, Rico S, Rodríguez I, Guillén J, Arroyo FJ, Bernal S, Espigares R, Núñez M, Escribano A, Barrionuevo JL, Gentil J, Barrios V, Fernández-Nistal A, Martos-Moreno GA, Martínez V, Argente J.

J Endocrinol Invest. 2011 Apr;34(4):300-6. doi: 10.3275/7169. Epub 2010 Jul 13.

PMID:
20634639

Supplemental Content

Loading ...
Support Center